• Coronavirus OC43 (CoV-OC43)
  • Coronavirus NL63 (CoV-NL63)
  • Coronavirus 229E (CoV-229E)
  • Coronavirus HKU1 (CoV-HKU1)
  • Parainfluenza virus 4 (PIV4)
  • Human Rhinovirus (hRV)
  • Human Enterovirus (hEV)
  • Human Bocavirus (hBoV)
  • Human Metapneumovirus (hMPV)

RV PCR Panel B - 9 Viruses Dubai – Common Cold & Endemic Coronavirus Detection at Home

Vesta Care's RV PCR Panel B delivers specialized detection of 9 respiratory viruses causing common cold symptoms and endemic respiratory illness through convenient at-home nasal swab collection. This focused molecular diagnostic panel identifies the viral pathogens responsible for the majority of mild to moderate upper respiratory infections in Dubai—endemic coronaviruses, rhinovirus, enterovirus, and other common cold viruses—providing diagnostic clarity when symptoms overlap with more serious respiratory infections.

At AED 399, this targeted viral panel distinguishes common cold viruses from influenza, RSV, and COVID-19 when respiratory symptoms emerge. Our DHA-licensed healthcare professionals collect your nasal swab sample at home with same-day scheduling and convenient delivery, with results arriving within 48 hours identifying which virus caused your infection and enabling appropriate clinical management.

Why Common Cold Virus Testing Matters

Rhinoviruses are the most frequent viral infectious agent in humans and the predominant cause of the common cold, causing at least 50% of cold infections. However, distinguishing common cold viruses from more serious respiratory pathogens based on symptoms alone proves impossible, as fever, cough, sore throat, and fatigue appear across dozens of different infections.

This 9-virus panel solves a critical diagnostic challenge: identifying whether your respiratory symptoms stem from common cold viruses requiring only supportive care, or whether testing for more serious pathogens becomes necessary. Understanding the specific causative virus prevents unnecessary medical interventions, avoids inappropriate antibiotic prescriptions, and provides accurate prognosis information for recovery expectations.

Complete Viral Coverage

Human Rhinovirus (hRV): Rhinoviruses cause more than half of cold-like illnesses and circulate throughout the world year-round, resulting in untold medical expense and lost productivity. With over 100 distinct serotypes existing, these viruses cause sore throat, runny nose, nasal congestion, sneezing, and cough—typically lasting 7-10 days with supportive care being the only treatment. While usually mild, rhinoviruses can trigger severe asthma exacerbations and cause lower respiratory tract infections in infants, elderly, and immunocompromised individuals.

Human Enterovirus (hEV): Enteroviruses are among the most common infectious agents worldwide, capable of causing illnesses ranging from the common cold to more serious conditions like aseptic meningitis, myopericarditis, hand-foot-mouth disease, and encephalitis. Most infections produce mild cold-like symptoms including fever, rash, runny nose, and muscle aches, though certain strains like Enterovirus D68 can cause severe respiratory illness with wheezing and breathing difficulties, particularly dangerous in children with asthma. PCR testing cannot differentiate rhinovirus from enterovirus, so results report them together as they're closely related viruses requiring similar clinical management.

Coronavirus OC43 (CoV-OC43): One of four endemic human coronaviruses causing seasonal common cold symptoms circulating continuously in populations. This betacoronavirus typically produces mild upper respiratory infection with runny nose, cough, and sore throat, though it occasionally causes lower respiratory tract disease in elderly and immunocompromised individuals. OC43 circulates year-round with winter peaks, representing a significant proportion of common cold cases during cooler months.

Coronavirus NL63 (CoV-NL63): An endemic alphacoronavirus causing common cold symptoms along with croup in young children. This seasonal virus produces upper respiratory symptoms including fever, cough, and rhinorrhea, occasionally progressing to bronchiolitis or pneumonia in vulnerable populations. NL63 shows seasonal patterns with late winter and spring peaks, contributing substantially to respiratory illness during these periods in children and adults.

Coronavirus 229E (CoV-229E): Another endemic alphacoronavirus causing mild to moderate upper respiratory tract infections. This virus produces typical cold symptoms—nasal congestion, sore throat, cough, and mild fever—circulating continuously with seasonal increases during winter months. While usually causing only mild illness, 229E can occasionally produce lower respiratory tract infections in immunocompromised patients requiring medical attention.

Coronavirus HKU1 (CoV-HKU1): An endemic betacoronavirus causing seasonal respiratory illness similar to other common cold coronaviruses. HKU1 produces upper respiratory symptoms including rhinorrhea, cough, and fever, with winter seasonality patterns similar to OC43. Though typically causing mild disease, this virus occasionally produces pneumonia or bronchiolitis in elderly patients, young children, and those with underlying respiratory conditions requiring hospitalization.

Parainfluenza Virus 4 (PIV4): The least common and least studied parainfluenza virus causing mild upper respiratory tract infections. PIV4 produces cold-like symptoms including cough, rhinorrhea, and low-grade fever, generally causing less severe illness than PIV1-3. This virus circulates sporadically without clear seasonal patterns, occasionally detected in children with respiratory symptoms though its exact clinical significance remains less well-defined than other parainfluenza types.

Human Bocavirus (hBoV): A relatively recently discovered parvovirus associated with respiratory illness primarily in young children. Bocavirus causes upper respiratory symptoms and occasionally lower respiratory tract infections including bronchiolitis and pneumonia. Often detected alongside other respiratory viruses in coinfections, making its independent clinical significance challenging to determine, though correlation with respiratory symptoms—particularly wheezing—is well established in pediatric populations.

Human Metapneumovirus (hMPV): A pneumovirus causing respiratory infections ranging from common cold symptoms to severe bronchiolitis and pneumonia. Discovered in 2001, hMPV produces symptoms similar to RSV including cough, fever, nasal congestion, and wheezing, particularly affecting young children, elderly, and immunocompromised individuals. This virus circulates with winter and spring peaks, representing a major cause of hospitalization for respiratory illness in children under five and elderly patients with underlying conditions.

Who Benefits from This Test

This 9-virus panel serves individuals experiencing respiratory symptoms where diagnostic clarity provides value: persistent cold symptoms lasting beyond typical 7-10 day duration, respiratory illness in vulnerable populations including young children or elderly where virus identification guides monitoring decisions, cases requiring documentation for workplace or school return policies, and situations where distinguishing common cold viruses from COVID-19 or influenza matters for isolation protocols.

Healthcare workers, teachers, and parents particularly benefit from definitive diagnosis distinguishing common cold viruses from more serious pathogens requiring enhanced precautions. Patients with asthma or chronic respiratory conditions benefit from rhinovirus/enterovirus identification as these viruses frequently trigger dangerous exacerbations requiring medication adjustment.

Check also: RV PCR Panel A

The Home Testing Process

Vesta Care delivers professional respiratory virus testing throughout Dubai with same-day collection scheduling. Our DHA-licensed healthcare professionals arrive at your location equipped with proper nasal swab collection supplies and following hygiene protocols appropriate for respiratory illness.

The nasal swab collection takes seconds—a sterile swab inserted into your nostril and rotated to collect respiratory secretions. Your sealed sample reaches our certified laboratory where advanced PCR technology simultaneously detects all 9 viruses from the single specimen. Results arrive within 48 hours via email and SMS, clearly identifying which virus or viruses caused your infection.

Clinical Value and Management

Test results provide important clinical guidance. Detection of common cold viruses confirms viral etiology preventing unnecessary antibiotic prescriptions, provides accurate recovery timeline expectations (7-10 days for most cold viruses), and identifies specific viruses requiring enhanced monitoring in vulnerable patients. Rhinovirus/enterovirus detection in asthma patients alerts physicians to potential exacerbation risks requiring preventive intervention.

Metapneumovirus or bocavirus detection in young children or elderly patients triggers appropriate monitoring for progression to lower respiratory tract disease. Endemic coronavirus identification confirms mild illness expected with supportive care only, distinguishing these viruses from COVID-19 requiring isolation protocols.

Book Your Respiratory Virus Panel

Schedule your RV PCR Panel B test through our online platform. Select your preferred collection time, provide basic information, and our healthcare professional arrives with necessary supplies. Results reach you within 48 hours—accurate, comprehensive, and clinically actionable.

At AED 399, Vesta Care provides specialized detection of common cold viruses and endemic respiratory pathogens, delivering diagnostic clarity when distinguishing mild from serious respiratory illness matters. Book now for same-day collection.

Testimonials

What Our patients are saying

Frequently asked questions

How does Lab at Home service work?

All medical providers in Dubai are subject to the same rules and regulations of DHA and are obliged to perform laboratory investigations in a licensed by DHA medical laboratory. Vesta Care is bringing this service to your home. We maintain the required clinical standards, ensuring accuracy and credibility, while we support you in getting the help you need at your convenience avoiding the hassles and risks of a hospital visit. With us you pay for your tests only, not for our building costs.

Which types of lab tests can be conducted at home?

We have the widest list of biomarkers that can be performed by any medical laboratory in Dubai. Most importantly however with Vesta Care you get access to our licensed by DHA specialist and the unique and fully customizable health and wellness packages.

Is the Lab at Home service available for all locations in Dubai?

Vesta Care is licensed by Dubai Health Authority and authorized to operate near you and anywhere in Dubai, from Dubai Investment Park (DIP), Dubai Marina, Al Barsha up to the outskirts of Deira and the borders with Sharjah and Fujairah. You can reach us anytime around the clock and we will be with your anywhere in Dubai and near you, within less than an hour from your call.

What are the benefits of choosing Lab at Home a visit to a clinic or hospital?

Your sample and laboratory investigation will follow the same route, regardless of the collection point, as all samples are processed by a separate DHA licensed Laboratory. The benefits of using the Vesta Care’s lab at home service near you are that we are a one-stop-solution (as we have the widest list of biomarkers available),  you avoid the loss of time and slot availability in a medical facility, you face no queue nor you are exposed to any hazards visiting a clinic or hospital. All of these at your location, near you, always available and a cost that is a fraction of what a hospital would charge you – while not providing you with the services we do.

Can I request a specific type of lab test not listed on the website?

We are providing access to over 1,900 biomarkers locally available in the UAE through our exclusive medical laboratories. If we don’t have it, no one does. Challenge us, we are available any day and time to receive your query and provide you with clinical solutions you never though were possible before.

How can I schedule an appointment for Lab at Home services?

There are many ways for you to reach us, we have made that simple! You can call us, text us, whatsapp us or email us and very shortly a member of our patient engagement team will handle your query with priority and provide a solution that fits your needs. You are our best embassador of our quality and convenience, and we treat you as such.

How credible and accurate are your lab results?

We are a licensed medical provider by Dubai Health Authority and thus we are obliged to work with licensed medical laboratories.
We are proud of our partnership with Dubai’s oldest and most credible, for over 20 years, medical laboratory, Intel Lab. Our exclusive partner warrants the credibility and accuracy of our results while we warrant the compliance on sample collection and transportation. We together ensure that your results are credible while also being delivered without intermediaries that can hurt quality.
What makes Vesta Care different is that we do not stop in just processing and reporting your results, every sample, before it is released, is clinically correlated by our most senior Clinical Pathologist in Dubai to ensure not only accuracy but clinical correlation too.

How soon can I expect to receive my test results?

Vesta Care has fully optimized its processes end to end for the lab at home services, utilizing the most modern technologies available. We ensure that your sample is received in the medical laboratory minutes after is being collected, while on a priority basis your samples are processed. The majority of the biomarkers are run and reported within the same day while the vast majority of our tests are reported within 24hours the latest. We normally do not exceed 3-5 calendar dates even for the most complex, rare or technically demanding parameters. Remember, Vesta Care warrants the quality of its services and we are always ready to accept the consequences of any delay (regardless of its origin) and compensate you.

What safety measures are in place during lab at home visits?

Fortunately for all, we have Dubai Health Authority’s rules and regulators governing this for us. Our team is licensed within the scope of our work and we are proudly subject to extensive, diligent and very frequent audits from the regulator on all our activities. We welcome that and embrace it. During your appointment you should expect our medical experts to wear PPEs while all medical instruments used to be well calibrated and inspected according to DHA’s protocols. Your biggest protection however, is our commitment before the visit since we operate under the code of conduct of our medical profession and we do not commercialize healthcare for financial benefit. Contact us and you will understand the difference.

What payment options are available for Lab at Home services?

We have available all the generally accepted forms of payments for your transactions; excluding e-coins. We accept transfers, debit / credit cards or Tabby payments – we also accept cash payments. Please ensure that you have received a valid electronic invoice within 24hours from your interaction with us or contact us.

The Program includes

RV PCR Panel B - 9 Viruses Dubai – Common Cold & Endemic Coronavirus Detection at Home

Vesta Care's RV PCR Panel B delivers specialized detection of 9 respiratory viruses causing common cold symptoms and endemic respiratory illness through convenient at-home nasal swab collection. This focused molecular diagnostic panel identifies the viral pathogens responsible for the majority of mild to moderate upper respiratory infections in Dubai—endemic coronaviruses, rhinovirus, enterovirus, and other common cold viruses—providing diagnostic clarity when symptoms overlap with more serious respiratory infections.

At AED 399, this targeted viral panel distinguishes common cold viruses from influenza, RSV, and COVID-19 when respiratory symptoms emerge. Our DHA-licensed healthcare professionals collect your nasal swab sample at home with same-day scheduling and convenient delivery, with results arriving within 48 hours identifying which virus caused your infection and enabling appropriate clinical management.

Why Common Cold Virus Testing Matters

Rhinoviruses are the most frequent viral infectious agent in humans and the predominant cause of the common cold, causing at least 50% of cold infections. However, distinguishing common cold viruses from more serious respiratory pathogens based on symptoms alone proves impossible, as fever, cough, sore throat, and fatigue appear across dozens of different infections.

This 9-virus panel solves a critical diagnostic challenge: identifying whether your respiratory symptoms stem from common cold viruses requiring only supportive care, or whether testing for more serious pathogens becomes necessary. Understanding the specific causative virus prevents unnecessary medical interventions, avoids inappropriate antibiotic prescriptions, and provides accurate prognosis information for recovery expectations.

Complete Viral Coverage

Human Rhinovirus (hRV): Rhinoviruses cause more than half of cold-like illnesses and circulate throughout the world year-round, resulting in untold medical expense and lost productivity. With over 100 distinct serotypes existing, these viruses cause sore throat, runny nose, nasal congestion, sneezing, and cough—typically lasting 7-10 days with supportive care being the only treatment. While usually mild, rhinoviruses can trigger severe asthma exacerbations and cause lower respiratory tract infections in infants, elderly, and immunocompromised individuals.

Human Enterovirus (hEV): Enteroviruses are among the most common infectious agents worldwide, capable of causing illnesses ranging from the common cold to more serious conditions like aseptic meningitis, myopericarditis, hand-foot-mouth disease, and encephalitis. Most infections produce mild cold-like symptoms including fever, rash, runny nose, and muscle aches, though certain strains like Enterovirus D68 can cause severe respiratory illness with wheezing and breathing difficulties, particularly dangerous in children with asthma. PCR testing cannot differentiate rhinovirus from enterovirus, so results report them together as they're closely related viruses requiring similar clinical management.

Coronavirus OC43 (CoV-OC43): One of four endemic human coronaviruses causing seasonal common cold symptoms circulating continuously in populations. This betacoronavirus typically produces mild upper respiratory infection with runny nose, cough, and sore throat, though it occasionally causes lower respiratory tract disease in elderly and immunocompromised individuals. OC43 circulates year-round with winter peaks, representing a significant proportion of common cold cases during cooler months.

Coronavirus NL63 (CoV-NL63): An endemic alphacoronavirus causing common cold symptoms along with croup in young children. This seasonal virus produces upper respiratory symptoms including fever, cough, and rhinorrhea, occasionally progressing to bronchiolitis or pneumonia in vulnerable populations. NL63 shows seasonal patterns with late winter and spring peaks, contributing substantially to respiratory illness during these periods in children and adults.

Coronavirus 229E (CoV-229E): Another endemic alphacoronavirus causing mild to moderate upper respiratory tract infections. This virus produces typical cold symptoms—nasal congestion, sore throat, cough, and mild fever—circulating continuously with seasonal increases during winter months. While usually causing only mild illness, 229E can occasionally produce lower respiratory tract infections in immunocompromised patients requiring medical attention.

Coronavirus HKU1 (CoV-HKU1): An endemic betacoronavirus causing seasonal respiratory illness similar to other common cold coronaviruses. HKU1 produces upper respiratory symptoms including rhinorrhea, cough, and fever, with winter seasonality patterns similar to OC43. Though typically causing mild disease, this virus occasionally produces pneumonia or bronchiolitis in elderly patients, young children, and those with underlying respiratory conditions requiring hospitalization.

Parainfluenza Virus 4 (PIV4): The least common and least studied parainfluenza virus causing mild upper respiratory tract infections. PIV4 produces cold-like symptoms including cough, rhinorrhea, and low-grade fever, generally causing less severe illness than PIV1-3. This virus circulates sporadically without clear seasonal patterns, occasionally detected in children with respiratory symptoms though its exact clinical significance remains less well-defined than other parainfluenza types.

Human Bocavirus (hBoV): A relatively recently discovered parvovirus associated with respiratory illness primarily in young children. Bocavirus causes upper respiratory symptoms and occasionally lower respiratory tract infections including bronchiolitis and pneumonia. Often detected alongside other respiratory viruses in coinfections, making its independent clinical significance challenging to determine, though correlation with respiratory symptoms—particularly wheezing—is well established in pediatric populations.

Human Metapneumovirus (hMPV): A pneumovirus causing respiratory infections ranging from common cold symptoms to severe bronchiolitis and pneumonia. Discovered in 2001, hMPV produces symptoms similar to RSV including cough, fever, nasal congestion, and wheezing, particularly affecting young children, elderly, and immunocompromised individuals. This virus circulates with winter and spring peaks, representing a major cause of hospitalization for respiratory illness in children under five and elderly patients with underlying conditions.

Who Benefits from This Test

This 9-virus panel serves individuals experiencing respiratory symptoms where diagnostic clarity provides value: persistent cold symptoms lasting beyond typical 7-10 day duration, respiratory illness in vulnerable populations including young children or elderly where virus identification guides monitoring decisions, cases requiring documentation for workplace or school return policies, and situations where distinguishing common cold viruses from COVID-19 or influenza matters for isolation protocols.

Healthcare workers, teachers, and parents particularly benefit from definitive diagnosis distinguishing common cold viruses from more serious pathogens requiring enhanced precautions. Patients with asthma or chronic respiratory conditions benefit from rhinovirus/enterovirus identification as these viruses frequently trigger dangerous exacerbations requiring medication adjustment.

Check also: RV PCR Panel A

The Home Testing Process

Vesta Care delivers professional respiratory virus testing throughout Dubai with same-day collection scheduling. Our DHA-licensed healthcare professionals arrive at your location equipped with proper nasal swab collection supplies and following hygiene protocols appropriate for respiratory illness.

The nasal swab collection takes seconds—a sterile swab inserted into your nostril and rotated to collect respiratory secretions. Your sealed sample reaches our certified laboratory where advanced PCR technology simultaneously detects all 9 viruses from the single specimen. Results arrive within 48 hours via email and SMS, clearly identifying which virus or viruses caused your infection.

Clinical Value and Management

Test results provide important clinical guidance. Detection of common cold viruses confirms viral etiology preventing unnecessary antibiotic prescriptions, provides accurate recovery timeline expectations (7-10 days for most cold viruses), and identifies specific viruses requiring enhanced monitoring in vulnerable patients. Rhinovirus/enterovirus detection in asthma patients alerts physicians to potential exacerbation risks requiring preventive intervention.

Metapneumovirus or bocavirus detection in young children or elderly patients triggers appropriate monitoring for progression to lower respiratory tract disease. Endemic coronavirus identification confirms mild illness expected with supportive care only, distinguishing these viruses from COVID-19 requiring isolation protocols.

Book Your Respiratory Virus Panel

Schedule your RV PCR Panel B test through our online platform. Select your preferred collection time, provide basic information, and our healthcare professional arrives with necessary supplies. Results reach you within 48 hours—accurate, comprehensive, and clinically actionable.

At AED 399, Vesta Care provides specialized detection of common cold viruses and endemic respiratory pathogens, delivering diagnostic clarity when distinguishing mild from serious respiratory illness matters. Book now for same-day collection.

Testimonials

What Our patients are saying

Frequently asked questions

How often should I get IV therapy?

It depends on the targeted treatment and desired outcomes. IV therapy can be given as a one-off treatment to provide you with a nutrient boost. For all the therapies the results will be evident from the first therapy. Some therapies involve a weekly infusion for 3-6 weeks at most but still the results are evident from the first and each subsequent one.

How long does the IV therapy lasts?

Most of the therapies on our dosages take between 25 – 45 mins, with the longer ones reaching up to 1hour. The duration of the therapy depends mostly on the competency of the injected kit.

Is IV therapy more effective than oral supplements?

Yes, micronutrients and vitamins are absorbed at a rate of 10-20% when oral taken as opposed to the efficiency of the IV therapy where the absorption is between 90-100%.

Is the process Painful?

The procedure is performed by a licensed and trained phlebotomist / nurse, under supervision of the treating physician and does not differ to standard injections. Our team is well trained to provide a smooth process. Normally, you should not feel pain during the injection or post the injection.

Will I notice the difference?

Absolutely yes. We are not inventing the wheel, we are simply delivering it to your house ensuring the consumables we use are potent and accredited, from reputable and licensed manufacturers, and approved for use by the Health Authorities while its delivery is performed by licensed professional clinicians. All our IV therapies will deliver a noticeable difference from first therapy and when multiple therapies are needed all will reinforce the prior experience until reaching the desired outcomes.

x
x